| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Cash flows provided by (used in) investing activities | 29,765 | 29,765 |
| Proceeds from issuance of ordinary shares under employee share plans | 28 | 28 |
| Cash flows provided by financing activities | 28 | 28 |
| Net decrease in cash, cash equivalents and restricted cash | -56,849 | -38,368 |
| Cash and cash equivalents at beginning of period | 117,431 | - |
| Cash and cash equivalents at end of period | 60,582 | - |
Mural Oncology plc (MURA)
Mural Oncology plc (MURA)